CircCFL1/MiR-107 Axis Targeting HMGB1 Promotes the Malignant Progression of Diffuse Large B-Cell Lymphoma Tumors
Author:
Publisher
Informa UK Limited
Subject
Oncology
Reference33 articles.
1. A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL
2. Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation
3. Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure
4. Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCL
5. Clinical significance of elevated antinuclear antibodies in patients with diffuse large B-cell lymphoma: A single center study
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The potential role and mechanism of circRNAs in foam cell formation;Non-coding RNA Research;2023-09
2. MIR-107/HMGB1/FGF-2 axis responds to excessive mechanical stretch to promote rapid repair of vascular endothelial cells;Archives of Biochemistry and Biophysics;2023-08
3. Circular RNA circ_0000877 serves as a miR-671-5p sponge to regulate diffuse large B-cell lymphoma development via HK2;Molecular & Cellular Toxicology;2022-10-14
4. Hsa_circ_0000877 facilitates the progression of diffuse large B-cell lymphoma by miR-370-3p/mitogen-activated protein kinase kinase kinase kinase 4/Hippo pathway;Anti-Cancer Drugs;2022-09-30
5. MiR-107 inhibits the malignant biological behavior of esophageal squamous cell carcinoma by targeting TPM3;Journal of Gastrointestinal Oncology;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3